New oral therapy of CETP inhibition for lipid lowering - PACE-CME

New oral therapy of CETP inhibition for lipid lowering

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

No role of Lp(a) in thrombosis
No role of Lp(a) in thrombosis
EAS 2022
No role of Lp(a) in thrombosis
- Prof. Alberico Catapano, PhD
GLP-1RA as new treatment option on the horizon for obesity
GLP-1RA as new treatment option on the horizon for obesity
EAS 2022
GLP-1RA as new treatment option on the horizon for obesity
- Prof. Ulrich Laufs, MD, PhD
Wake-up call to shift focus from treating CVD to preserving CV health
Wake-up call to shift focus from treating CVD to preserving CV health
EAS 2022
Wake-up call to shift focus from treating CVD to preserving CV health
- Prof. Lale Tokgözoğlu, MD
Targeting the ANGPTL3 pathway for lowering TG-rich lipoproteins
Targeting the ANGPTL3 pathway for lowering TG-rich lipoproteins
EAS 2022
Targeting the ANGPTL3 pathway for lowering TG-rich lipoproteins
- Nicholas Marston, MD